EUR 2.38
(4.39%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.07 Million EUR | -23.89% |
2022 | 1.41 Million EUR | 27.33% |
2021 | 1.11 Million EUR | 0.17% |
2020 | 1.1 Million EUR | 29.32% |
2019 | 857.24 Thousand EUR | -17.9% |
2018 | 1.04 Million EUR | 40.11% |
2017 | 745.25 Thousand EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 517.26 Thousand EUR | 0.0% |
2023 Q4 | 827.54 Thousand EUR | 0.0% |
2023 FY | 1.07 Million EUR | -23.89% |
2023 Q2 | 248.61 Thousand EUR | 0.0% |
2022 FY | 1.41 Million EUR | 27.33% |
2022 Q2 | 678.65 Thousand EUR | 0.0% |
2022 Q4 | 735.36 Thousand EUR | 0.0% |
2021 Q2 | 390.6 Thousand EUR | 0.0% |
2021 FY | 1.11 Million EUR | 0.17% |
2021 Q4 | 719.94 Thousand EUR | 0.0% |
2020 Q4 | 764.3 Thousand EUR | 0.0% |
2020 Q2 | 344.3 Thousand EUR | 0.0% |
2020 FY | 1.1 Million EUR | 29.32% |
2019 Q3 | 114.52 Thousand EUR | -81.77% |
2019 FY | 857.24 Thousand EUR | -17.9% |
2019 Q4 | 229.05 Thousand EUR | 100.0% |
2019 Q2 | 628.18 Thousand EUR | 0.0% |
2018 Q4 | 745.3 Thousand EUR | 0.0% |
2018 FY | 1.04 Million EUR | 40.11% |
2018 Q2 | 298.84 Thousand EUR | 0.0% |
2017 FY | 745.25 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Philogen S.p.A. | -6.16 Million EUR | 117.467% |
Ulisse Biomed S.p.A. | -4.79 Million EUR | 122.435% |